Video-on-Demand Library

Play

This content is restricted to members of PSI. If you are already a member please login. To join PSI or to see all the benefits of membership click here.

PSI Scientific Meeting: Patient-focused drug development scientific meeting (Part2)

19 October 2023

Dr. Byron Jones, Dr. Brett Hauber, Dr. Bennett Levitan, Dr. Christine Sturchler, Dr. Hannah Penton, Dr. Marco Boeri, Teodora Trasieva.

Day 2 of the patient-focused drug development meeting presented 3 industry case studies and finished with a panel discussion:
“The importance of different symptoms to people living with Chronic Obstructive Pulmonary Disease (COPD): results of a multi-country patient preference study. Industry case (Novartis)”, presented by Dr. Byron Jones, Biostatistician Specialising in Patient Preference Studies in the Patient Engagement Science group at Novartis

“Using Patient Preferences to Inform Dose Selection”, presented by Dr. Brett Hauber, Senior Director, Patient Preferences in Worldwide Medical and Safety of Pfizer

“The relevance of fatigue to relapse rate in multiple sclerosis: Applying patient preference data to the OPTIMUM trial”, presented by Dr. Bennett Levitan, Senior Director, Benefit-risk Assessment, Department of Epidemiology at Johnson & Johnson

Panel discussion, including Dr. Byron Jones, Dr. Brett Hauber, Dr. Bennett Levitan, Dr. Christine Sturchler, Dr. Hannah Penton, Dr. Marco Boeri.

Part of Collection(s)

Topic(s)

Upcoming Events

PSI Introduction to Industry Training (ITIT) Course - 2025/2026

An introductory course giving an overview of the pharmaceutical industry and the drug development process as a whole, aimed at those with 1-3 years' experience. It comprises of six 2-day sessions covering a range of topics including Research and Development, Toxicology, Data Management and the Role of a CRO, Clinical Trials, Reimbursement, and Marketing.

Joint PSI/EFSPI Visualisation SIG 'Wonderful Wednesday' Webinars

Our monthly webinar explores examples of innovative data visualisations relevant to our day to day work. Each month a new dataset is provided from a clinical trial or other relevant example, and participants are invited to submit a graphic that communicates interesting and relevant characteristics of the data.

PSI Career Young Virtual Event (Q2 2025)

This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.

PSI Webinar: Applying the Estimand Framework to Clinical Pharmacology Trials with a Case Study in Bioequivalance

This will be a 45 minute webinar which will explain the topic presented in the published paper, ‘Applying the Estimand Framework to Clinical Pharmacology Trials with a Case Study in Bioequivalance’. There will be 15 minutes for a panel Q&A with some of the authors following the presentation.

PSI Webinar: Methodology and first results of the iRISE (improving Reproducibility In SciencE) consortium

This 1-hour webinar will be an opportunity to hear about the methodology and first results of the iRISE consortium. iRISE is working towards a better understanding of reproducibility and the interventions that work to improve it. At the end of the presentation there will also be the opportunity to ask questions.

Latest Jobs

Principal Statistician - Labcorp

This is an exciting, new opportunity for an experienced Statistician looking to take the next step in their career. Offered as a remote or hybrid position aligned with our site in Harrogate, North Yorkshire.